ERA-话题@MedSci

#ERA#

425篇内容 | 3145人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1739062, encodeId=6d2e1e3906220, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Biomed Res Int：ERAP1基因多态性与银屑病易感性之间的关系, objectType=article, longId=219554, objectId=1fd4219554fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fd4219554fc, replyNumber=0, likeNumber=86, createdTime=2022-02-25, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fd4219554fc, moduleTitle=Biomed Res Int：ERAP1基因多态性与银屑病易感性之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fd4219554fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739056, encodeId=c4571e3905605, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=2019年EULAR/ERA-EDTA：狼疮肾炎治疗建议的新进展, objectType=article, longId=217631, objectId=2ca721e6319b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ca721e6319b, replyNumber=0, likeNumber=78, createdTime=2021-10-07, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ca721e6319b, moduleTitle=2019年EULAR/ERA-EDTA：狼疮肾炎治疗建议的新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ca721e6319b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739051, encodeId=611b1e3905147, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=辉瑞以 23 亿美元收购抗癌药物公司Trillium Therapeutics，溢价203.8%, objectType=article, longId=216230, objectId=0d962162302d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d962162302d, replyNumber=0, likeNumber=80, createdTime=2021-12-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d962162302d, moduleTitle=辉瑞以 23 亿美元收购抗癌药物公司Trillium Therapeutics，溢价203.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d962162302d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739095, encodeId=41c61e3909580, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：低聚钠GV-971, 改善痴呆或有效, objectType=article, longId=220323, objectId=7c9f22032315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c9f22032315, replyNumber=0, likeNumber=65, createdTime=2022-09-14, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c9f22032315, moduleTitle=Alz Res Therapy：低聚钠GV-971, 改善痴呆或有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c9f22032315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739106, encodeId=82331e3910608, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Signalling entrains the peripheral circadian clock, objectType=article, longId=221046, objectId=26bf221046d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26bf221046d4, replyNumber=0, likeNumber=42, createdTime=2022-06-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26bf221046d4, moduleTitle=Signalling entrains the peripheral circadian clock, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26bf221046d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739055, encodeId=af0b1e39055cb, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle= Journal of Physiotherapy ：患者教育可改善膝骨关节炎患者的疼痛和功能，与运动疗法结合使用效果更佳！, objectType=article, longId=216731, objectId=3230216e31ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3230216e31ad, replyNumber=0, likeNumber=91, createdTime=2022-06-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3230216e31ad, moduleTitle= Journal of Physiotherapy ：患者教育可改善膝骨关节炎患者的疼痛和功能，与运动疗法结合使用效果更佳！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3230216e31ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739107, encodeId=c3861e391076f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Low Dose Radiation Increased the Therapeutic Efficacy of Cyclophosphamide on S180 Sarcoma Bearing Mice, objectType=article, longId=221058, objectId=db9a221058ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db9a221058ec, replyNumber=0, likeNumber=54, createdTime=2022-07-14, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db9a221058ec, moduleTitle=Low Dose Radiation Increased the Therapeutic Efficacy of Cyclophosphamide on S180 Sarcoma Bearing Mice, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db9a221058ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739091, encodeId=87521e39091f6, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy: 脑脊液中有哪些蛋白质，和tau-Aβ相关, objectType=article, longId=220235, objectId=1f8a220235e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8a220235e5, replyNumber=0, likeNumber=51, createdTime=2022-10-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8a220235e5, moduleTitle=Alz Res Therapy: 脑脊液中有哪些蛋白质，和tau-Aβ相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8a220235e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739094, encodeId=b4171e3909458, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy: 抑郁+脑血管病，痴呆风险大大增加, objectType=article, longId=220322, objectId=ecfd220322a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecfd220322a2, replyNumber=0, likeNumber=48, createdTime=2022-05-09, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecfd220322a2, moduleTitle=Alz Res Therapy: 抑郁+脑血管病，痴呆风险大大增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecfd220322a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739052, encodeId=6fa71e390527d, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=RubrYc Therapeutics宣布与iBio, Inc.达成A2轮优先股权融资、合作协议及RTX-003许可, objectType=article, longId=216365, objectId=235721636565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=235721636565, replyNumber=0, likeNumber=69, createdTime=2022-04-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=235721636565, moduleTitle=RubrYc Therapeutics宣布与iBio, Inc.达成A2轮优先股权融资、合作协议及RTX-003许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=235721636565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739037, encodeId=95271e390371e, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活, objectType=article, longId=206733, objectId=aed0206e3371, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aed0206e3371, replyNumber=0, likeNumber=66, createdTime=2021-02-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aed0206e3371, moduleTitle=Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aed0206e3371)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739082, encodeId=a1d31e3908293, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：简易认知量表测试，或可辅助筛查阿尔兹海默症病理筛查, objectType=article, longId=219966, objectId=3aeb219966bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aeb219966bb, replyNumber=0, likeNumber=65, createdTime=2022-02-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aeb219966bb, moduleTitle=Alz Res Therapy：简易认知量表测试，或可辅助筛查阿尔兹海默症病理筛查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aeb219966bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739088, encodeId=2f941e39088a2, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy: 未患糖尿病的痴呆患者，胰岛素抵抗可反映神经退行性变化, objectType=article, longId=220135, objectId=f88c220135e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f88c220135e9, replyNumber=0, likeNumber=62, createdTime=2021-11-23, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f88c220135e9, moduleTitle=Alz Res Therapy: 未患糖尿病的痴呆患者，胰岛素抵抗可反映神经退行性变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f88c220135e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739034, encodeId=7c6f1e3903439, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Artiva Biotherapeutics宣布与默克公司达成**全球合作和许可协议，以开发候选CAR-NK细胞疗法, objectType=article, longId=206408, objectId=55db20640853, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55db20640853, replyNumber=0, likeNumber=91, createdTime=2021-08-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55db20640853, moduleTitle=Artiva Biotherapeutics宣布与默克公司达成**全球合作和许可协议，以开发候选CAR-NK细胞疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55db20640853)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739042, encodeId=97231e3904224, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=沃比医疗Esperance®远端通路导管中国上市，脑卒中介入治疗器械迎来临床新选择, objectType=article, longId=210567, objectId=69d221056ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69d221056ea2, replyNumber=0, likeNumber=77, createdTime=2022-03-07, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69d221056ea2, moduleTitle=沃比医疗Esperance®远端通路导管中国上市，脑卒中介入治疗器械迎来临床新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69d221056ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739050, encodeId=62a71e3905031, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=肺部手术的加速康复外科（ERAS）实施策略, objectType=article, longId=216063, objectId=ade521606345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ade521606345, replyNumber=0, likeNumber=69, createdTime=2021-10-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ade521606345, moduleTitle=肺部手术的加速康复外科（ERAS）实施策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ade521606345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739049, encodeId=6c071e39049d1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Neural Regeneration Research：脑胰岛素抵抗是唐氏综合征阿尔茨海默病发展的早期危险因素, objectType=article, longId=214895, objectId=d59c21489526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d59c21489526, replyNumber=0, likeNumber=79, createdTime=2022-02-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d59c21489526, moduleTitle=Neural Regeneration Research：脑胰岛素抵抗是唐氏综合征阿尔茨海默病发展的早期危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d59c21489526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739039, encodeId=12df1e3903960, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=武田将收购Maverick Therapeutics，以推进T细胞接合治疗实体瘤，扩大新型免疫肿瘤产品组合, objectType=article, longId=208266, objectId=376920826667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=376920826667, replyNumber=0, likeNumber=72, createdTime=2021-11-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=376920826667, moduleTitle=武田将收购Maverick Therapeutics，以推进T细胞接合治疗实体瘤，扩大新型免疫肿瘤产品组合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=376920826667)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739043, encodeId=a0c21e390431b, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Stem Cell Research & Therapy：miR-424-5p可用作早期心脏病的生物标志物, objectType=article, longId=211351, objectId=5be02113516a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5be02113516a, replyNumber=0, likeNumber=74, createdTime=2022-02-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5be02113516a, moduleTitle=Stem Cell Research & Therapy：miR-424-5p可用作早期心脏病的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5be02113516a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739048, encodeId=53741e39048fc, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=LegoChem Biosciences与Iksuda Therapeutics扩大抗体药物偶联物开发许可协议, objectType=article, longId=213183, objectId=364e2131837c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364e2131837c, replyNumber=0, likeNumber=67, createdTime=2021-09-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364e2131837c, moduleTitle=LegoChem Biosciences与Iksuda Therapeutics扩大抗体药物偶联物开发许可协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364e2131837c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Biomed Res Int：ERAP1基因多态性与银屑病易感性之间的关系

2022-02-25

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

2019年EULAR/ERA-EDTA：狼疮肾炎治疗建议的新进展

2021-10-07

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

辉瑞以 23 亿美元收购抗癌药物公司Trillium Therapeutics，溢价203.8%

2021-12-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：低聚钠GV-971, 改善痴呆或有效

2022-09-14

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Signalling entrains the peripheral circadian clock

2022-06-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Journal of Physiotherapy ：患者教育可改善膝骨关节炎患者的疼痛和功能，与运动疗法结合使用效果更佳！

2022-06-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Low Dose Radiation Increased the Therapeutic Efficacy of Cyclophosphamide on S180 Sarcoma Bearing Mice

2022-07-14

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy: 脑脊液中有哪些蛋白质，和tau-Aβ相关

2022-10-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy: 抑郁+脑血管病，痴呆风险大大增加

2022-05-09

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

RubrYc Therapeutics宣布与iBio, Inc.达成A2轮优先股权融资、合作协议及RTX-003许可

2022-04-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活

2021-02-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：简易认知量表测试，或可辅助筛查阿尔兹海默症病理筛查

2022-02-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy: 未患糖尿病的痴呆患者，胰岛素抵抗可反映神经退行性变化

2021-11-23

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Artiva Biotherapeutics宣布与默克公司达成**全球合作和许可协议，以开发候选CAR-NK细胞疗法

2021-08-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

沃比医疗Esperance®远端通路导管中国上市，脑卒中介入治疗器械迎来临床新选择

2022-03-07

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

肺部手术的加速康复外科（ERAS）实施策略

2021-10-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Neural Regeneration Research：脑胰岛素抵抗是唐氏综合征阿尔茨海默病发展的早期危险因素

2022-02-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

武田将收购Maverick Therapeutics，以推进T细胞接合治疗实体瘤，扩大新型免疫肿瘤产品组合

2021-11-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Stem Cell Research & Therapy：miR-424-5p可用作早期心脏病的生物标志物

2022-02-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

LegoChem Biosciences与Iksuda Therapeutics扩大抗体药物偶联物开发许可协议

2021-09-21

科室
- - 订阅+
  - 更多科室
工具
服务